Consolidation therapy is necessary following successful biofeedback treatment for pubertal chronic prostatitis patients: A 3-year follow-up study - Abstract

OBJECTIVE: To assess long-term effects of biofeedback training on pubertal chronic prostatitis (CP).

METHODS: Pubertal CP patients received 12-week intensive biofeedback training and were divided into two groups: group 1 received further monthly training ≥24 (26-36) months; group 2 received further monthly training < 24 (13-23) months. National Institutes of Health-CP Symptom Index (NIH-CPSI) scores, maximum urinary flow rate (Qmax) and postvoid residual urine volume (PVR) were recorded monthly.

RESULTS: Total NIH-CPSI scores decreased significantly in group 1 (n = 10; mean age ± SD 16.5 ± 1.1 years) together with all subdomain scores (pain, urination, life impact). Total NIH-CPSI scores increased significantly in group 2 (n = 12; mean age ± SD 16.3 ± 1.2 years) at 30 and 36 months, and were significantly different from group 1 at these time points. Urination and life-impact scores increased significantly and Qmax decreased significantly in group 2 at 30 and 36 months. PVR was unchanged in either group.

CONCLUSIONS: Twelve-week intensive biofeedback training requires lengthy consolidation sessions to achieve long-term success. Further investigation should assess longer intervals between consolidation sessions, for improving patient compliance and outcome.

Written by:
Wang J, Qi L, Zhang XY, Dai YQ, Li Y.   Are you the author?
Department of Urology, Xiang Ya Hospital, Central South University, Changsha City, Hunan Province, China.

Reference: J Int Med Res. 2013 Feb 6. Epub ahead of print.

PubMed Abstract
PMID: 23569039 Prostatitis Section







Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.